Cefdinir and Botox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Botox (botulinum toxin type a). Common drug interactions include pneumonia among females and altered state of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Botox. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.



On Aug, 03, 2026

31 people who take Cefdinir and Botox together, and have interactions are studied.

Cefdinir and Botox drug interactions.

What are the common drug interactions of Cefdinir and Botox, by gender? *:

female:

  1. Pneumonia
  2. Fatigue (feeling of tiredness)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Abdominal pain upper
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cataract (clouding of the lens inside the eye)
  7. Erythema (redness of the skin)
  8. Eye irritation
  9. Eye swelling
  10. Influenza

male:

  1. Altered state of consciousness (altered state of mind)
  2. Cardiac ventricular thrombosis (blood clot in ventricle)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  5. Muscle spasms (muscle contraction)
  6. Nausea (feeling of having an urge to vomit)
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Subdural haematoma (blood collects between the skull and the surface of the brain)
  9. Urinary tract infection
  10. Chills (felling of cold)

What are the common drug interactions of Cefdinir and Botox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Altered state of consciousness (altered state of mind)
  2. Hydrocephalus (water on the brain)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Subdural haematoma (blood collects between the skull and the surface of the brain)

10-19:

n/a

20-29:

  1. Obstruction
  2. Pain
  3. Peripheral swelling
  4. Procedural pain
  5. Pyrexia (fever)
  6. Staphylococcal infection (an infection with staphylococcus bacteria)
  7. Swelling face
  8. Tearfulness (excess tearing)
  9. Urinary tract infection
  10. Vomiting

30-39:

  1. Influenza
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Asthma
  4. Therapeutic response unexpected
  5. Blood pressure increased
  6. Breast mass
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Feeling drunk
  9. Food poisoning (poison in food)
  10. Headache (pain in head)

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Infection
  3. Upper respiratory tract infection
  4. Cough
  5. Hypertension (high blood pressure)
  6. Infusion site pain
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Pneumonia
  9. Post procedural infection
  10. Tongue geographic (irregular patches on the surface of the tongue)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  3. Herpes zoster
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Infusion related reaction
  6. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  7. Muscle spasms (muscle contraction)
  8. Nausea (feeling of having an urge to vomit)
  9. Oropharyngeal pain
  10. Pneumonia

60+:

  1. Death

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 19.35%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 16.13%
  3. Laxative Supportive Care: 5 people, 16.13%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.13%
  5. Immunodeficiency Common Variable: 3 people, 9.68%
  6. Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 2 people, 6.45%
  7. Stiff Person Syndrome: 2 people, 6.45%
  8. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 6.45%
  9. Pain: 2 people, 6.45%
  10. Myopathy (a muscular disease in which the muscle fibres do not function): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Botox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Botox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Botox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Botox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and botulinum toxin type a (the active ingredients of Cefdinir and Botox, respectively), and Cefdinir and Botox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: